The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler® in the treatment of asthma in the daily clinical practice.

Doniec, Zbigniew; Olszanecka-Glinianowicz, Magdalena; Hantulik, Piotr; Almgren-Rachtan, Agnieszka; Chudek, Jerzy

Doniec, Zbigniew; Olszanecka-Glinianowicz, Magdalena; Hantulik, Piotr; Almgren-Rachtan, Agnieszka; Chudek, Jerzy.

Afiliação

Doniec Z; Department of Pneumonology, Institute of Tuberculosis and Lung Diseases, Rabka-Zdrój, Poland.
Olszanecka-Glinianowicz M; Health Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Hantulik P; Orion Pharma Poland Co. Ltd, Warszawa, Poland.
Almgren-Rachtan A; Euromedic Medical Centre, Katowice, Poland.
Chudek J; Pathophysiology Unit, Department of Internal Diseases and Oncological Chemotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.

J Asthma ; 60(4): 754-760, 2023 04.

Article em En | MEDLINE | ID: mdl-35730239

Assuntos

Asma; Adulto; Humanos; Asma/tratamento farmacológico; Asma/induzido quimicamente; Fluticasona/efeitos adversos; Xinafoato de Salmeterol; Satisfação do Paciente; Combinação Fluticasona-Salmeterol/uso terapêutico; Resultado do Tratamento; Broncodilatadores/efeitos adversos; Androstadienos/efeitos adversos; Albuterol

Palavras-chave

asthma; fix-dose salmeterol/fluticasone combination therapy; patients satisfaction; real-life data

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma Tipo de estudo: Clinical_trials / Evaluation_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google